The most useful reframe is that procedures sit at a specific place in the treatment ladder: after medication, when it isn't enough, and not before. They are not experimental Hail Marys — deep brain stimulation has been used for essential tremor for over two decades (Chopra et al., Neuropsychiatr Dis Treat, 2013), and focused ultrasound is an established, incisionless option shown to significantly reduce tremor in a randomized trial (Elias et al., NEJM, 2016). Thinking of them as an absolute last resort is a common mistake, because it leads people to wait far longer than they need to. It's equally a mistake to imagine there's a single dramatic moment when a switch flips to "surgery now." In reality it's a gradual crossing of two thresholds — medication running out of road, and the tremor's toll on daily life mounting — and recognising those two signposts is what this comes down to.
The first and clearest signpost is that the medications have been given a real, adequate trial and still don't control the tremor enough. That means the first-line drugs — propranolol and primidone, both established as effective (Zesiewicz et al., Neurology, 2011) — tried at proper doses, often with a second-line drug added, without sufficient benefit. This is common, not a personal failure: first-line drugs fail to adequately control tremor in an estimated 25% to 55% of people (Bruno et al., Cochrane, 2017). "Exhausted medication" doesn't mean you've tried one pill; it means you and your doctor have worked through the reasonable options. An adequate trial matters here: a drug tried only briefly, or never increased past a low starting dose, hasn't really been tested. Before concluding the medications have failed, it's worth being sure each was given a fair chance — titrated up as far as you could tolerate, and combined where appropriate — and that reversible triggers like excess caffeine, stress, and poor sleep aren't quietly inflating the tremor. If you've done all that and control still isn't good enough, that's the genuine article: medication-refractory tremor, and the point where a procedure legitimately enters the conversation.
The second signpost is about impact, not appearance. The question isn't how big the tremor looks on an exam — it's whether it's genuinely disabling: stopping you eating in public, ending your ability to write or work, taking away independence. Essential tremor can be truly disabling and can impair quality of life (Schneider & Deuschl, Neurotherapeutics, 2014), and it's that functional cost — not a number — that makes a procedure worth its risks. A milder tremor that you manage well is a different situation from one that has reshaped your daily life.
If you reach the point of considering surgery, the decision usually comes down to two established procedures, and knowing the basic shape of each helps you have the conversation. Deep brain stimulation (DBS) implants a thin electrode connected to a pacemaker-like device; it's adjustable, largely reversible, and can treat both sides, at the cost of being surgery with hardware. Focused ultrasound (MRgFUS) is incisionless — it uses focused sound waves to treat the tremor-generating area, with no implant and often a fairly quick result — but it works by making a permanent lesion, and is typically done on one side. Both are established for medication-refractory essential tremor (Chopra et al., 2013; Elias et al., NEJM, 2016). You don't need to pick between them yourself; the point is to know they're the two paths the specialist assessment will help you choose between, and a companion guide goes deeper on what DBS is actually like.
Meeting the two signs above opens the door, but candidacy is a fuller picture that a specialist assesses. It generally includes a confident diagnosis of essential tremor (procedures target ET specifically, so the diagnosis needs to be right), tremor that is both medication-refractory and disabling, general health that makes a procedure reasonable, and realistic expectations about the result. Deep brain stimulation and focused ultrasound each have their own candidacy considerations — for example around treating one or both sides — which is part of what the assessment sorts out.
In practice, this is a process, not a single yes-or-no. It usually starts with a referral to a movement-disorder specialist, who confirms the diagnosis, reviews everything you've tried, and assesses how much the tremor is limiting you. If a procedure is on the table, the conversation turns to which one — deep brain stimulation or focused ultrasound — fits your situation and what matters to you. It's a shared decision made with a team, and there's no prize for rushing it; taking the time to understand the options is exactly right.
A few questions are worth bringing to that discussion, so the appointment works for you:
- Given my specific tremor, how much improvement is realistic — and how likely?
- Which procedure do you recommend for me, and why that one over the other?
- What are the main risks and side effects in my case, and how reversible are they?
- What does recovery look like, and how long until I'd feel the benefit?
- What happens if it doesn't work as hoped — what options remain?
Writing down your own answers to "how is the tremor actually affecting my life" beforehand also helps the specialist see the functional picture that a brief exam can miss.
Almost everyone hesitates, and that's healthy — this is real surgery, and taking it seriously is the right instinct. The trap to avoid is the opposite one: waiting so long, out of fear, that you lose years of function you could have regained. The people who come through it best tend to reach the same realization — that at some point the tremor's daily cost outgrew the fear of the procedure, and that waiting was quietly costing them more than the surgery would. You are far from alone in weighing it; the community is full of people at exactly this crossroads:
If your tremor has crossed both thresholds — medication exhausted, life meaningfully limited — it is reasonable, not premature, to ask your doctor for a referral to discuss it.